Ashley Kauth, RN, FNP-C Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1509 Cataluna Pl, Palos Verdes Estates, CA 90274 Phone: 310-961-7210 |
Mrs. Patricia Alice Elder, RN, IBCLC Registered Nurse - Lactation Consultant Medicare: Not Enrolled in Medicare Practice Location: 1648 Via Arriba, Palos Verdes Estates, CA 90274 Phone: 310-378-1958 |
Ryan Conahan, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 380 Palos Verdes Dr W, Palos Verdes Estates, CA 90274 Phone: 310-483-5384 |
News Archive
Teenage boys in Sweden take less responsibility than girls for preventing the spread of chlamydia and other sexually transmitted infections, according to a new study from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
Meridian Bioscience, Inc. was awarded 1st place for innovation in emergency treatment and point-of-care testing for its illumigene Malaria test at the 2016 JIB/ACNBH Conference this summer.
Antibe Therapeutics Inc. ("Antibe" or the "Corporation") is pleased to announce that it has completed its planned pre-clinical program for its lead product ATB-346 to support initial clinical studies in humans.
It's a sound that saves. A "real-time" radiation monitor that alerts by beeping in response to radiation exposure during cardiac-catheterization procedures significantly reduces the amount of exposure that medical workers receive, UT Southwestern Medical Center researchers found.
Cytokine PharmaSciences, Inc. today announced the completion of a Phase II study of the misoprostol vaginal insert (MVI), a proprietary, controlled-release and retrievable polymer chip containing prostaglandin E(1) (PGE1). Results of the dose-finding study in pregnant women at term gestation confirm the efficacy and safety of this investigational product and suggest that the MVI may reduce time to delivery after induction, support more natural labor, and reduce the rate of cesarean delivery.
› Verified 6 days ago